Assays

Items 21-30 of 52

per page
Set Descending Direction
  1. ITCH E3 Ligase TR-FRET Kit
    SBB-KF0035
    SBB-KF0035-KI011 Kit
    CHF 1'250.00
    ITCH E3 Ligase TR-FRET Kit
  2. MDA5 ATPase FI Assay System
    BBL-3036-FI
    BBL-3036-FI-1K1000 assays
    CHF 1'010.00
    BBL-3036-FI-10K10000 assays
    CHF 3'418.00
    BBL-3036-FI-100K10 x 10000 assaysINQ
    NEW MDA5 ATPase FI Assay System
  3. MDA5 ATPase FP Assay System
    BBL-3036-FP
    BBL-3036-FP-1K1000 assays
    CHF 1'010.00
    BBL-3036-FP-10K10000 assays
    CHF 3'418.00
    BBL-3036-FP-100K10 x 10000 assaysINQ
    NEW MDA5 ATPase FP Assay System
  4. MDA5 ATPase TR-FRET Assay System
    BBL-3036-TR
    BBL-3036-TR-1K1000 assays
    CHF 1'010.00
    BBL-3036-TR-10K10000 assays
    CHF 3'418.00
    BBL-3036-TR-100K10 x 10000 assaysINQ
    NEW MDA5 ATPase TR-FRET Assay System
  5. MDM2 E3 Ligase TR-FRET Kit
    SBB-KF0030
    SBB-KF0030-KI011 Kit
    CHF 1'250.00
    MDM2 E3 Ligase TR-FRET Kit
  6. Nedd4 E3 Ligase TR-FRET Kit
    SBB-KF0056
    SBB-KF0056-KI011 Kit
    CHF 1'250.00
    % Signal to Background of Continuous Real-Time TR-FRET Parkin titration (autoubiquitination): Serial dilutions of Parkin W403A from 50nM to 3.125nM and 300nM wt Parkin were mixed with UBA1, UBE2D3 and trf-Ub (pS65) mix. Reactions were initiated wit
  7. PARG Assay System
    BBL-3033
    BBL-3033-1K1000 assays
    CHF 1'227.00
    BBL-3033-10K10000 assays
    CHF 5'072.00
    BBL-3033-100K10 x 10000 assaysINQ
    PARG Assay System
  8. Parkin E3 Ligase TR-FRET Kit
    SBB-KF0036
    SBB-KF0036-KI011 Kit
    CHF 1'250.00
    Parkin E3 Ligase TR-FRET Kit
  9. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  10. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us

Items 21-30 of 52

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.